Skip to main content
OIDA Image Collection
Filters:
Reset 
A slide from a presentation that shows Debra an example Exalgo patient at her three-month follow up. The slide has a white background with black text. On the right side of the slide there is a photo of a woman's face with her hand on her chin smiling.<br /><br />Four bullet points describe the Clinical Outcome of her 3-Month Follow-up. The first bullet point reads: "Maintained on one 32 mg tablet daily with adequate analgesia and tolerable side effects."  An image of an example maintenance prescription is shown. The second bullet point reads: "Debra continues to require <2 doses of supplemental analgesia within a 24-hour period." The third bullet point reads: "Debra's persistent pain rating is 3-4 and her RMDQ score is 8." The fourth bullet point reads: "Her pain interferes less with her daily activities and she has been able to return to steady work."<br /><br />On the bottom right corner it says "See additional important risk information including full-boxed warning on back cover of your booklet. See full-prescription information inside the booklet." There is also there a logo for Exalgo at the bottom right corner.

Description Generated using AI

A slide from a presentation that shows Debra an example Exalgo patient at her three-month follow up. The slide has a white background with black text. On the right side of the slide there is a photo of a woman's face with her hand on her chin smiling.

Four bullet points describe the Clinical Outcome of her 3-Month Follow-up. The first bullet point reads: "Maintained on one 32 mg tablet daily with adequate analgesia and tolerable side effects." An image of an example maintenance prescription is shown. The second bullet point reads: "Debra continues to require <2 doses of supplemental analgesia within a 24-hour period." The third bullet point reads: "Debra's persistent pain rating is 3-4 and her RMDQ score is 8." The fourth bullet point reads: "Her pain interferes less with her daily activities and she has been able to return to steady work."

On the bottom right corner it says "See additional important risk information including full-boxed warning on back cover of your booklet. See full-prescription information inside the booklet." There is also there a logo for Exalgo at the bottom right corner.

We encourage you to view the image in the context of its source document(s) and cite the source(s) when using these images. However, to cite just this image alone, click the “Cite This Image” button and then paste the copied text.

Information copied to your clipboard:

"A slide from a presentation that shows Debra an example Exalgo patient at her three-month follow up. The slide has a white background with black text...